RedHill Biopharma Ltd. (RDHL)
$0.54-6.90%Close
SELLRECOVERY · day 2
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $2M
- Beta
- 4.90
- P/E (TTM)
- -3.56
- Short % float
- 9.26%
- Days to cover
- 1.6
- SI change
- -10.2%
- 1W
- +8.00%
- 1M
- -16.92%
- vs SPY 1W
- +6.84%
- vs SPY 1M
- -19.92%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on RDHL?
- LOPJLB’s latest quantitative signal on RedHill Biopharma Ltd. (RDHL) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is RDHL in?
- RedHill Biopharma Ltd. (RDHL) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does RedHill Biopharma Ltd. (RDHL) do?
- RedHill Biopharma Ltd. is a specialized pharmaceutical firm concentrating its efforts mainly on therapies for digestive tract conditions and various infections. The company markets several gastrointestinal medications: Movantik, which addresses opioid-induced constipation in adults experiencing chronic non-cancer pain; Talicia, used to treat Helicobacter pylori infections in adult patients; and…